Table 2 |
||||
|
Characteristics of the eight BW-MVPs that were prioritized for further validation using DBS |
||||
|
CpG number |
Region |
Gene/ element |
Full name |
Function |
|
|
||||
|
cg14123607 |
Intron 1/insulator |
APBA1 |
Amyloid beta A4 precursor protein-binding family A member 1 |
Associated with reduced production of amyloid-β peptide, which is considered a key player in Alzheimer's disease [52] |
|
cg12170649 |
Intron 2/enhancer |
APPL2 |
Adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
Involved in cell proliferation and embryonic development. Acts as negative controller of adiponectin signaling and SNPs in APPL2 have been associated with obesity [53-55] |
|
cg26404226 |
Enhancer |
Chr10q23.3 |
||
|
cg15487251a |
Promoter |
IGF2BP2 |
Insulin-like growth factor 2 mRNA-binding protein 2 |
mRNA binding protein involved in RNA localization, stability and translation. Intronic SNP in IGF2BP2 has been identified as T2D risk factor by several GWAS [56] |
|
cg10362113a |
Intron 1/weak enhancer |
PAPOLA |
Poly(A) polymerase alpha |
Plays a predominant role in addition of the 3'-poly(A) tail to mRNA precursors, which is important for mRNA stability, transport and translation [57] |
|
cg02409150 |
Intron 4 |
PHKG2 |
Phosphorylase kinase, gamma 2 (testis) |
Encodes the gamma subunit of the liver-specific phosphorylase kinase, which activates the enzyme glycogen phosphorylase, resulting in glycogen breakdown [58] |
|
cg15049370a |
Intron 2/enhancer |
PPARGC1B |
Peroxisome proliferator-activated receptor gamma coactivator 1-beta |
Multifunctional transcriptional co-regulator involved in many metabolic processes, including mitochondrial oxidative metabolism and hepatic lipogenesis [59] |
|
cg22768222 |
Intron 1/weak enhancer |
RUNX2 |
Runt-related transcription factor 2 |
Transcription factor essential for osteoblast and chondrocyte differentiation [60] |
|
|
||||
|
aAffected by buccal content. BW-MVP, birth weight-associated methylation variable position; DBS, deep bisulfite sequencing; GWAS, genome-wide association studies; SNP, single nucleotide polymorphism; T2D, type 2 diabetes. |
||||
|
Souren et al. Genome Biology 2013 14:R44 doi:10.1186/gb-2013-14-5-r44 |
||||